Accenture has Big Plans For Outsourcing Services

The Financial Express reports that Accenture is planning to expand the scope of its life science centre in India and its capabilities of clinical trials.

Arjun Bedi, Global Lead of Accenture’s Health & Life Sciences R&D practice, mentions:

“There is a new wave in the outsourcing of the R&D model from in-house innovation engine to a virtual innovation network. A new dichotomy is being identified in the research process with virtual transformation in the front end and a development factory at the back end.’

Pharmaceutical growth is threathened by rising costs and decreasing budgets, and clinical trials are only becoming more complex and rigorous. Perhaps pharma R&D outsourcing might the solution, but pharma companies have been slow in adapting to R&D outsourcing because of concerns such as diverse portfolio applications, regulatory requirements, security and domain expertise.